|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01548 GENSCRIPT BIO
Nominal 
32.560 +3.200 (+10.899%) | 2026/06 - Interim USD(K$) | 2025/12 USD(K$) | 2024/12 USD(K$) | 2023/12 USD(K$) | 2022/12 USD(K$) | |
| Net Cash from / (used in) Operating Activities | -- | 325,522 | 75,647 | (286,911) | (120,292) |
| Net Cash from / (used in) Investing Activities | -- | (171,951) | (1,456,363) | (357,728) | (443,296) |
| Net Cash from / (used in) Financing Activities | -- | (144,889) | 66,519 | 1,068,260 | 419,317 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 8,682 | (1,314,197) | 423,621 | (144,271) |
| Cash & Cash Equivalents at beginning of period | -- | 131,990 | 1,446,403 | 1,023,999 | 1,180,971 |
| Effect of Foreign Exchange Rate Changes | -- | 1,816 | (216) | (1,217) | (12,701) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 142,488 | 131,990 | 1,446,403 | 1,023,999 |
| Remarks: | Real time quote last updated: 20/08/2026 09:35 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K$) | USD -129,343 |
| %Change | 407.984% |
| EPS / (LPS) | USD -0.059 |
| NBV Per Share ($) | USD 1.776 |